Big River Industries Limited (ASX:BRI)

Market Cap	119.97M
Revenue (ttm)	408.04M
Net Income (ttm)	-16.08M
Shares Out	85.39M
EPS (ttm)	-0.19
PE Ratio	n/a
Forward PE	16.65
Dividend	0.04 (2.84%)
Ex-Dividend Date	Mar 3, 2025

Volume	11,899
Average Volume	16,035
Open	1.405
Previous Close	1.410
Day's Range	1.400 - 1.405
52-Week Range	1.140 - 1.760
Beta	-0.04
RSI	53.01
Earnings Date	Aug 26, 2025

About Theseus Pharmaceuticals

Big River Industries Limited, together with its subsidiaries, engages in the manufacture, distribution, and retail of timber and building products in Australia and New Zealand. The company operates through two segments, Panels and Construction. It offers building materials, such as building products, pine framing, fibre cement, LVL, I-beams and laminated beams, structural and decorative hardwoods, plywood, sheet materials, timber moldings, particle board flooring, landscape and fencing supplies, timber flooring and decking, doors, door furnitur...

• Industry: Lumber & Wood Production
• Sector: Materials
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: BRI

Financial Performance

In 2024, Big River Industries's revenue was 414.93 million, a decrease of -7.68% compared to the previous year's 449.45 million. Earnings were 8.03 million, a decrease of -63.77%.